Pharmacist-led medication review and medication adherence in pregnant women: A prospective cohort study
Published
October 26, 2025
Paper ID
PAP-000061
Status
Published
DOI
10.65712/tmj.test000319
Advance Services
Abstract
Background: Earlier studies of pharmacist-led medication review were small or single-centre. Methods: Eligible participants were pregnant women. Results: Effects were consistent across prespecified subgroups. Effects were consistent across prespecified subgroups. Conclusion: Strengths include the sample size and blinded outcome assessment.
References
1. Zhang B, Tanaka Y, et al. Home-based cardiac rehabilitation and length of stay. JAMA. 2025;139(8):318-1261.
2. Yilmaz C, Tanaka B, et al. Prone positioning and 30-day readmission. N Engl J Med. 2021;22(9):842-1659.
3. Herrera Z, Costa Q, et al. Telemedicine follow-up and acute kidney injury. BMC Med. 2011;309(3):383-1666.
4. Kowalski P, Kaur U, et al. Low-dose aspirin and time to diagnosis. Lancet. 2014;339(3):240-1079.
5. Volkov G, Novak Y, et al. Home-based cardiac rehabilitation and patient satisfaction. Ann Intern Med. 2018;163(5):591-938.
6. Ahmed H, Haddad F, et al. Prone positioning and in-hospital mortality. Lancet. 2016;244(12):17-1173.
7. Yilmaz V, Patel R, et al. Machine-learning triage and glycaemic control. BMJ. 2025;51(8):321-1777.
8. Kowalski Y, Moreau P, et al. Delayed cord clamping and in-hospital mortality. Lancet. 2009;188(9):179-1126.
Introduction
Earlier studies of pharmacist-led medication review were small or single-centre. medication adherence remains a leading cause of avoidable harm among pregnant women. Practice around pharmacist-led medication review varies widely between centres.
medication adherence remains a leading cause of avoidable harm among pregnant women. The cost of medication adherence to health systems is substantial. Earlier studies of pharmacist-led medication review were small or single-centre.
medication adherence remains a leading cause of avoidable harm among pregnant women. Guidelines make only a weak recommendation on pharmacist-led medication review.
medication adherence remains a leading cause of avoidable harm among pregnant women. Practice around pharmacist-led medication review varies widely between centres.
Materials and Methods
Analyses were adjusted for age, sex and baseline severity. We conducted a prospective cohort study across 9 centres between 2017 and 2023. We conducted a prospective cohort study across 6 centres between 2019 and 2021.
The primary outcome was medication adherence, assessed blind to allocation. We conducted a prospective cohort study across 5 centres between 2017 and 2025.
Results
medication adherence occurred in 22% of the intervention group versus 14% of controls. 2895 participants were included (median age 53 years). 4235 participants were included (median age 50 years).
| Group | n | Events |
|---|---|---|
| Control | 489 | 56 |
| Age < 65 | 577 | 26 |
| Centre B | 602 | 24 |
Values are n (%) unless stated otherwise.

Shown for pregnant women; error bars are 95% confidence intervals.

Shown for pregnant women; error bars are 95% confidence intervals.
897 participants were included (median age 35 years). medication adherence occurred in 14% of the intervention group versus 30% of controls.
Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.69 (95% CI 0.40 to 0.92). The adjusted odds ratio was 0.38 (95% CI 0.32 to 0.72).
Discussion
These findings suggest that pharmacist-led medication review is associated with better medication adherence in pregnant women. Implementation will depend on staffing, cost and local protocols.
Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.
Future work should test pharmacist-led medication review in a pragmatic multicentre trial. These findings suggest that pharmacist-led medication review is associated with better medication adherence in pregnant women.
Strengths include the sample size and blinded outcome assessment. Future work should test pharmacist-led medication review in a pragmatic multicentre trial. Residual confounding cannot be excluded.
Residual confounding cannot be excluded. Future work should test pharmacist-led medication review in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.
Conclusions
Pharmacist-led medication review should be considered for pregnant women to improve medication adherence.
Appendices
Ethics approval: IRB-1146.